Olveira, A.; Augustin, S.; Benlloch, S.; Ampuero, J.; Suárez-Pérez, J.A.; Armesto, S.; Vilarrasa, E.; Belinchón-Romero, I.; Herranz, P.; Crespo, J.;
et al. The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life 2023, 13, 419.
https://doi.org/10.3390/life13020419
AMA Style
Olveira A, Augustin S, Benlloch S, Ampuero J, Suárez-Pérez JA, Armesto S, Vilarrasa E, Belinchón-Romero I, Herranz P, Crespo J,
et al. The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life. 2023; 13(2):419.
https://doi.org/10.3390/life13020419
Chicago/Turabian Style
Olveira, Antonio, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo,
and et al. 2023. "The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease" Life 13, no. 2: 419.
https://doi.org/10.3390/life13020419
APA Style
Olveira, A., Augustin, S., Benlloch, S., Ampuero, J., Suárez-Pérez, J. A., Armesto, S., Vilarrasa, E., Belinchón-Romero, I., Herranz, P., Crespo, J., Guimerá, F., Gómez-Labrador, L., MartÃn, V., & Carrascosa, J. M.
(2023). The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life, 13(2), 419.
https://doi.org/10.3390/life13020419
